Taken together, preclinical and clinical studies have demonstrated that GLP-1 receptor agonists exert pleiotropic effects extending beyond glycemic control, influencing multiple organ systems including the nervous, respiratory, hepatic, renal, cardiovascular, reproductive, and immune systems (Figure 4)
This non-GMO approach is particularly advantageous in the food and cosmetic industry applications, where consumer preference and regulatory frameworks often favor non-GMOs (Adalja et al., 2023
Moving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug reward
All cells in any given vertebrate express MHC, but most cells only express MHC class I
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA, et al